Egyptian International Pharmaceutical Investments (CAI:PHAR) 3-Year Revenue Growth Rate : 15.60% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments 3-Year Revenue Growth Rate?

Egyptian International Pharmaceutical Investments's Revenue per Share for the three months ended in Dec. 2023 was E£10.42.

During the past 12 months, Egyptian International Pharmaceutical Investments's average Revenue per Share Growth Rate was 14.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 15.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Egyptian International Pharmaceutical Investments was 20.80% per year. The lowest was 5.10% per year. And the median was 10.05% per year.

Competitive Comparison of Egyptian International Pharmaceutical Investments's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Egyptian International Pharmaceutical Investments's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's 3-Year Revenue Growth Rate falls into.

Egyptian International Pharmaceutical Investments 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Egyptian International Pharmaceutical Investments (CAI:PHAR) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Egyptian International Pharmaceutical Investments 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY

Website

http://www.eipico.com.eg

Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.